Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
AOD-9604 received FDA GRAS (Generally Recognized As Safe) status as a food ingredient in 2007, but this is not drug approval
Proposed mechanisms of AOD-9604: Stimulates lipolysis (fat breakdown) Increases fat oxidation Promotes mobilization of stored fat Influences lipid metabolism Importantly, AOD-9604 does not appear to significantly increase growth hormone levels, IGF-1 levels, water retention, or organ growth
Most people report improvement in fatigue and anemia symptoms within 2472 hours after the first injection, especially with severe deficiency
It stimulates collagen production, reduces inflammation, and promotes wound healing
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that supports energy production and DNA repair at the cellular level
In supervised protocols, BPC-157 is commonly dosed at 250 to 500 mcg per day subcutaneously, while TB-500 uses about 2.5 mg twice weekly for weeks 1 to 6, then about 2.5 mg once weekly for maintenance
